To include your compound in the COVID-19 Resource Center, submit it here.

Orchard raises $110M series B

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $110 million in a series B round led by Baillie Gifford and ORI Capital. Fellow new investors

Read the full 263 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE